1. Home
  2. RLAY vs WEN Comparison

RLAY vs WEN Comparison

Compare RLAY & WEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$9.15

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Wendy's Company (The)

WEN

Wendy's Company (The)

HOLD

Current Price

$7.88

Market Cap

1.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
RLAY
WEN
Founded
2015
1969
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
RLAY
WEN
Price
$9.15
$7.88
Analyst Decision
Strong Buy
Hold
Analyst Count
8
21
Target Price
$15.75
$9.76
AVG Volume (30 Days)
2.5M
7.2M
Earning Date
02-24-2026
02-13-2026
Dividend Yield
N/A
7.16%
EPS Growth
N/A
0.63
EPS
N/A
0.95
Revenue
$8,355,000.00
$2,208,190,000.00
Revenue This Year
$19.96
N/A
Revenue Next Year
N/A
$2.79
P/E Ratio
N/A
$8.27
Revenue Growth
N/A
N/A
52 Week Low
$1.78
$7.60
52 Week High
$9.25
$16.20

Technical Indicators

Market Signals
Indicator
RLAY
WEN
Relative Strength Index (RSI) 59.52 46.07
Support Level $8.08 $7.60
Resistance Level $9.25 $8.24
Average True Range (ATR) 0.67 0.27
MACD 0.12 -0.00
Stochastic Oscillator 83.02 39.44

Price Performance

Historical Comparison
RLAY
WEN

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

About WEN Wendy's Company (The)

The Wendy's Company is the second-largest burger quick-service restaurant, or QSR, chain in the United States by systemwide sales, with $12.6 billion in 2024, narrowly edging Burger King ($11.5 billion) and clocking in well behind wide-moat McDonald's ($51.1 billion). After divestitures of Tim Hortons (2006) and Arby's (2011), the firm manages just the burger banner, generating sales across a footprint that spanned more than 7,200 total stores in 30 countries as of year-end 2024. Wendy's generates revenue from the sale of hamburgers, chicken sandwiches, salads, and fries throughout its company-owned footprint, through franchise royalty and marketing fund payments remitted by its franchisees, which account for roughly 94% of stores, and through franchise flipping and advisory fees.

Share on Social Networks: